一般口演肝細胞癌治療

Mon. May 29, 2023 2:35 PM - 3:35 PM 第7会場 (ソニックシティビル4F 市民ホール第4集会室)

座長：井田良幸（和歌山県立医科大学第二内科），大川和良（大阪国際がんセンター肝胆膵内科）

+Add all to schedule

[96-消化-069] ABC conversion therapy for unresectable locally advanced hepatocellular carcinoma and contrast enhanced ultrasonography for adjuvant diagnosis of clinical complete response

Tomoko AOKI¹, Yasunori MINAMI¹, Hiroshi IDA¹, Hirokazu CHISHINA¹, Masahiro TAKITA¹, Satoru HAGIWARA¹, Kazuomi UESHIMA¹, Masakatsu TSURUSAKI², Naoshi NISHIDA¹, Masatoshi KUDO¹ (1.Department of gastroenterology and Hepatology, Kindai University Faculty of Medicine, 2.Department of Radiology, Kindai University Faculty of Medicine)

[96-消化-070] Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma by contrast-enhanced ultrasonography

Shinsuke UCHIKAWA, Tomokazu KAWAOKA, Hatsue FUJINO, Atsushi ONO, Takashi NAKAHARA, Eisuke MURAKAMI, Masami YAMAUCHI, Daiki MIKI, Michio IMAMURA, Shiro OKA (Department of Gastroenterology, Hiroshima University Hospital)

[96-消化-071] Usefulness of ultrasonography for the patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Kanami SHIMOKURI¹, Issei SAEKI², Tatsuya TAKAGI¹, Emii MORIGUCHI¹, Mikiko TABIRA¹, Hiroko NISHIKAWA¹, Norikazu TANABE¹, Mitsuaki NISHIOKA¹, Tarou TAKAMI², Takahiro YAMASAKI¹ (1.Division of Laboratory, Yamaguchi University Hospital, 2.Gastroenterology and Hepatology, Yamaguchi Univerisity Graduate School of Medicine)

[96-消化-072] Two cases of HCCs of successfully treated with ABC conversion therapy in which contrast-enhanced US was useful

Fumika MOTOKI¹, Chikara OGAWA², Rika MATSUMOTO², Kazutoshi FUKE², Takuya TODA², Kenshi MATSUURA², Takushi MANABE², Mitsushige SHIBATOGE², Masatoshi KUDO³ (1.Initial Clinical Intern, Takamatsu Red Cross Hospital, 2.Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, 3.Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine)

[96-消化-073] Microwave Ablation versus Laparoscopic Resection as First-line Therapy for Solitary 3–5 cm Hepatocellular Carcinoma

Ping LIANG (Department of Interventional Ultrasound, Chinese PLA Medical School)

[96-消化-074] Treatment outcome of Emprint Ablation System for malignant tumor

Tetsu TOMONARI, Hironori TANAKA, Tatsuya TANIGUCHI, Yutaka KAWANO, Hiroshi MIYAMOTO, Tetsuji TAKAYAMA (Department of Gastroenterology, Tokushima University Hospital)